These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8852504)

  • 1. Urinary crystals due to X-ray contrast medium.
    Sewell AC
    Nephron; 1996; 72(3):487-8. PubMed ID: 8852504
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physicochemical interpretation of the results of a test of lithogenic urine by a "LITOS-System" diagnosticum].
    Zaleskiĭ MG; Emanuel' VL
    Klin Lab Diagn; 2005 Dec; (12):19-23. PubMed ID: 16498948
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory methods of predicting primary and recurrent nephrolithiasis].
    Alchinbaev MK; Malik AM; Merkusheva NV; Makhonina IA
    Urologiia; 2000; (5):9-10. PubMed ID: 11392229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of urine fractionation on attachment of calcium oxalate crystals to renal epithelial cells: implications for studying renal calculogenesis.
    Grover PK; Thurgood LA; Ryall RL
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1396-403. PubMed ID: 17267387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Crystalluria and nephrolithiasis during therapy with the protease inhibitor indinavir].
    Rickerts V; Kober A; Stille W
    Dtsch Med Wochenschr; 1997 Jun; 122(24):803. PubMed ID: 9229567
    [No Abstract]   [Full Text] [Related]  

  • 6. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
    Khan SR; Glenton PA; Backov R; Talham DR
    Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine examination for calculogenic crystals in renal stone patients--a newer approach using refrigeration.
    Kumar A
    Trop Doct; 2004 Jul; 34(3):153-5. PubMed ID: 15267044
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracrystalline proteins and the hidden ultrastructure of calcium oxalate urinary crystals: implications for kidney stone formation.
    Lyons Ryall R; Fleming DE; Doyle IR; Evans NA; Dean CJ; Marshall VR
    J Struct Biol; 2001 Apr; 134(1):5-14. PubMed ID: 11469872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced crystallization inhibition by urine from men with nephrolithiasis.
    Asplin JR; Parks JH; Chen MS; Lieske JC; Toback FG; Pillay SN; Nakagawa Y; Coe FL
    Kidney Int; 1999 Oct; 56(4):1505-16. PubMed ID: 10504502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
    Khan SR
    Scanning Microsc; 1995 Jun; 9(2):597-614; discussion 614-6. PubMed ID: 8714752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary crystallization inhibitors do not prevent crystal binding.
    Schepers MS; van der Boom BG; Romijn JC; Schröder FH; Verkoelen CF
    J Urol; 2002 Apr; 167(4):1844-7. PubMed ID: 11912445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals.
    Asplin J; DeGanello S; Nakagawa YN; Coe FL
    Am J Physiol; 1991 Nov; 261(5 Pt 2):F824-30. PubMed ID: 1951713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and prevention of uric acid stones].
    Ferrari P; Bonny O
    Ther Umsch; 2004 Sep; 61(9):571-4. PubMed ID: 15493118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Crystallization inhibitory substances in urine and kidney calculi].
    Baumann JM; Ganz U; Felix R; Fleisch H; Rutishauser G
    Helv Chir Acta; 1974 Sep; 41(4):417-20. PubMed ID: 4369523
    [No Abstract]   [Full Text] [Related]  

  • 18. Low specific gravity urine with crystalluria as discriminant index for nephrolithiasis.
    Sriboonlue P; Prasongwattana V; Sriboonlue M; Chata K; Tungsanga K; Sitprija V
    J Med Assoc Thai; 1990 Nov; 73(11):634-40. PubMed ID: 2283493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration of a potent calcium oxalate monohydrate crystal growth inhibitor in the urine of normal persons and kidney stone patients by ELISA-based assay system employing monoclonal antibodies.
    Moghadam MF; Tandon C; Aggarwal S; Singla SK; Singh SK; Sharma SK; Varshney GC; Jethi RK
    J Cell Biochem; 2003 Dec; 90(6):1261-75. PubMed ID: 14635198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in vitro in the urine of healthy controls and stone-forming patients.
    Atmani F; Khan SR
    Urol Int; 2002; 68(1):54-9. PubMed ID: 11803269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.